Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
231901-2021 - Belgium-Brussels: Production, Priority-purchasing Options and Supply of Covid-19 Vaccines, Including Adapted Vaccines to SARS-CoV-2 Variants and Paediatric Formulations of such Vaccines for EU Member States
Luxembourg-Luxembourg: Analysis to Support Implementation of Articles 5, 6, 8 and 8c of Directive 2014/87/Euratom
Notice for changes or additional information
(Supplement to the Official Journal of the European Union, 2018/S 224-511786)
Section I: Contracting authority/entity
Section II: Object
Analysis to Support Implementation of Articles 5, 6, 8 and 8c of Directive 2014/87/Euratom
Council Directive 2009/71/Euratom as amended by Council Directive 2014/87/Euratom, (the Nuclear Safety Directive, hereafter “the Directive”) significantly strengthens the EU legal framework on nuclear safety. The Directive formulates a common basis for the management of nuclear safety, describing the essential administrative, technical and procedural requirements.The commission now wishes to broaden its analysis of the implementation of the Directive, focussing on several practical issues, namely; the responsibilities of the Competent Regulatory Authority (CRA) and the licence holder. In addition, the transparency requirements, in which both the CRA and the Licence Holder play an important role, should also be analysed.
Section VI: Complementary information
Section VII: Changes